This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Charité – Universitätsmedizin Berlin, Other. Active years: 2014-2018.
Company Filing History:
1 out of 283 
1 out of 834,453 Years Active: 2014-2018
Title: Ulrich Dirnagl: Innovator in Neuroprotection and Stroke Prevention
Introduction
Ulrich Dirnagl is a prominent inventor based in Berlin, Germany. He has made significant contributions to the fields of neuroprotection and stroke prevention through his innovative research and patented inventions. With a total of 2 patents, Dirnagl's work focuses on addressing critical medical conditions associated with tissue damage and inflammation.
Latest Patents
Dirnagl's latest patents include groundbreaking inventions that aim to improve treatment outcomes for patients suffering from neurological conditions. One of his notable patents is related to erythropoietin variants. This invention pertains to novel endogenous variants of erythropoietin (EPO) and their application in treating or preventing conditions linked to tissue damage due to cell death, such as apoptosis and necrosis. This is particularly relevant for neuroprotection in cases of acute and chronic diseases affecting the nervous system, including stroke and amyotrophic lateral sclerosis (ALS).
Another significant patent involves anti-infective agents and immunomodulators used for preventive therapy following an acute cerebrovascular accident. This invention focuses on agents designed to prevent infections after a stroke, utilizing anti-infective and immunomodulating agents, such as cytokines and inhibitors of the sympathetic nervous system, in pharmaceutical preparations.
Career Highlights
Dirnagl has had a distinguished career, working at Charité – Universitätsmedizin Berlin, one of the leading medical institutions in Europe. His research has been pivotal in advancing the understanding and treatment of neurological disorders.
Collaborations
Throughout his career, Dirnagl has collaborated with esteemed colleagues, including Andreas Meisel and Josef Priller. These collaborations have further enriched his research and contributed to the development of innovative therapeutic strategies.
Conclusion
Ulrich Dirnagl's contributions to the fields of neuroprotection and stroke prevention through his patents highlight his role as a leading inventor in medical research. His work continues to pave the way for advancements in treatment options for patients with neurological conditions.